Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beyond Medical Technologies Inc C.DOCT

Alternate Symbol(s):  DOCKF

Beyond Medical Technologies Inc. is a Canada-based company. The Company has no business operations and has no revenue. The Company is seeking new business opportunities.


CSE:DOCT - Post by User

Comment by JamesGreenon Nov 12, 2016 4:38pm
116 Views
Post# 25453617

RE:RE:RE:RE:FIN vs CGC

RE:RE:RE:RE:FIN vs CGC

Ya, it's pretty hard to justify a Billion $ marketcap with no profit. But, having visited both Aphria and Tweed I can see why they'll both be winners in the long run, with multibillion dollar caps

At Tweed there are about 100 people running around at all times, interns, graphic designers, a board room of execs pulling the latest financials, not to mention a really humble team of corporate execs, who seem to actually give a sh#t (instead of say... Aurora). Plus everyone i know who knows nothing about anything, knows of Tweed and Snoop (marketing)

At Aphria, all you see are plants lol, not a huge endless seam of ppl instead it's an endless skyline of greenhouses with rows and rows of either tomatoes and ornamental flowers. They're in Leamington where the sun is hot, and the days are long! They have a wonderful patient care unit, and a fantastic leadership team. They know and care about the bottom line, nuff said.

Different approaches, both winning, I think Finore fits a different model geared more towards Canopy's style of brand legacy and market capitalization, followed by hard numbers later

GLTA, remember to buy on rumours, sell on news, and oh ya... buy back of course

Bullboard Posts